News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,453 Results
Type
Article (13674)
Company Profile (100)
Press Release (249679)
Section
Business (87989)
Career Advice (464)
Deals (15337)
Drug Delivery (64)
Drug Development (36565)
Employer Resources (49)
FDA (6276)
Job Trends (6192)
News (150117)
Policy (14020)
Tag
Academia (435)
Alliances (23190)
Alzheimer's disease (374)
Approvals (6290)
Artificial intelligence (84)
Bankruptcy (144)
Best Places to Work (4369)
Breast cancer (67)
Cancer (479)
Cardiovascular disease (49)
Career advice (406)
Cell therapy (68)
Clinical research (30688)
Collaboration (262)
Compensation (109)
COVID-19 (753)
C-suite (84)
Data (468)
Diabetes (66)
Diagnostics (1287)
Drug discovery (45)
Drug pricing (59)
Earnings (31696)
Events (37109)
Executive appointments (291)
FDA (6569)
Funding (163)
Gene therapy (77)
GLP-1 (319)
Government (1277)
Healthcare (3547)
Infectious disease (778)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5862)
Job creations (2050)
Job search strategy (372)
Layoffs (173)
Legal (3423)
Lung cancer (68)
Manufacturing (119)
Medical device (1267)
Medtech (1269)
Mergers & acquisitions (9607)
Metabolic disorders (205)
Neuroscience (516)
NextGen: Class of 2025 (1583)
Non-profit (592)
Northern California (574)
Obesity (121)
Opinion (114)
Patents (76)
People (28703)
Pharmaceutical (64)
Phase I (7989)
Phase II (12978)
Phase III (11653)
Pipeline (250)
Policy (49)
Postmarket research (1401)
Preclinical (3183)
Radiopharmaceuticals (117)
Rare diseases (131)
Real estate (2632)
Regulatory (9961)
Research institute (563)
Resumes & cover letters (55)
Southern California (572)
Startups (1625)
United States (5723)
Vaccines (130)
Weight loss (87)
Date
Today (43)
Last 7 days (245)
Last 30 days (982)
Last 365 days (12405)
2025 (1312)
2024 (12499)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (46)
Asia (19971)
Australia (2583)
California (1374)
Canada (756)
China (178)
Colorado (57)
Connecticut (55)
Europe (39097)
Florida (240)
Illinois (161)
Indiana (110)
Japan (68)
Kansas (53)
Maryland (202)
Massachusetts (1175)
Minnesota (75)
New Jersey (579)
New York (388)
North Carolina (332)
Northern California (574)
Pennsylvania (351)
South America (500)
Southern California (572)
Texas (174)
Virginia (53)
Washington State (94)
263,453 Results for "biomunex pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology
December 3, 2024
·
8 min read
Genetown
Biomunex Signs Exclusive Licensing Agreement With Institut Curie to Develop MAIT Engagers, a New Class of Bispecific Antibodies in Immuno-oncology
Biomunex Pharmaceuticals announced the signature of an exclusive license and exploitation agreement with Institut Curie.
March 4, 2024
·
5 min read
Drug Development
Biomunex Pharmaceuticals Announces the Start of a Phase 1 Clinical Trial for Its First-in-class Bispecific Antibody for the Treatment of Cancer
This first-in-man trial conducted by Onward Therapeutics, under the license and co-development agreement, is a Phase 1 clinical trial for the evaluation of a bispecific antibody generated from Biomunex’ proprietary BiXAb® platform.
January 24, 2024
·
4 min read
Genetown
Biomunex Pharmaceuticals, a French Company Specialized in Immunotherapy, Presents the Latest Preclinical Results on Its Disruptive MAIT Cell Redirection Approach For Cancer Treatment at the 2023 AACR Annual Meeting
Biomunex Pharmaceuticals announced today that it will participate in and present new scientific data at the American Association for Cancer Research (AACR) annual meeting, which will take place from April 14th to April 19th, 2023 at the Orange County Convention Center, Orlando, Florida.
April 12, 2023
·
2 min read
Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology
Onward Therapeutics SA announced the execution of a worldwide exclusive license and co-development agreement with Biomunex Pharmaceuticals SAS, Paris, France, of a bispecific antibody targeting two immune checkpoints.
February 16, 2021
·
3 min read
Business
Biomunex Pharmaceuticals Establishes US Subsidiary
Biomunex Inc. to focus on R&D and business development activities in the US
May 28, 2019
·
3 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Layoffs
X4 Pharmaceuticals Stumbles Again, Laying Off 30% of Workforce
The headcount reduction will save money that the company will use in developing mavorixafor, its CXCR4 antagonist that last year received FDA approval to treat WHIM syndrome, in the larger patient population with chronic neutropenia.
February 6, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
January 30, 2025
·
1 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
1 of 26,346
Next
